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The Arp2/3 complex is a branched actin filament nucleator consisting of seven 
protein subunits. The Arp2/3 complex plays a crucial role in dynamic actin assembly, 
which is required for important cellular processes such as cell motility, cell division, 
chemotaxis, and phagocytosis. Previous studies have shown that Arp2/3 complex 
requires actin monomers, actin filaments, and nucleation-promoting factors such as 
W ASp for activation. However, it is still unclear how these factors cooperate to activate 
the Arp2/3 complex due to the lack of high resolution crystal structure of the active . 
... 'iit. 
Arp2/3 complex. This study seeks to develop biochemical probes to investigate th;-· 
structural changes that activate the Arp2/3 complex. We hypothesize that there will be 
an additional conformational change after Arp2 and Arp3 subunits form a pseudo dimer 
that allows the Arp2/3 complex to bind to the actin filaments and nucleate actin 
polymerization. We have developed a crosslinking assay with Saccharomyces 
cerevisiae Arp2/3 complex that contains double cysteine mutations at the nucleotide 
cleft to test for the new proposed conformational change in the Arp2/3 complex. I found 
that R64C/Q214C mutant successfully crosslinked with bis-maleimidoethane (BMOE), 
and the presence of ATP significantly decreased the crosslinking reaction rate. 
However, this study only shows the preliminary data and further studies are needed to 
investigate the role of actin filaments in the activation of Arp2/3 complex. 
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Introduction 
Actin is a highly conserved protein found in most eukaryotic organisms. Actin is 
the monomeric subunit of microfilaments and thin filaments, which are the major 
components of the cytoskeleton and the contractile apparatus in muscle cells, 
respectively (8).  The actin cytoskeleton is one of the major structural components of 
cells, and plays crucial roles in a number of dynamic cellular processes including cell 
migration, cytokinesis, membrane trafficking, and morphogenesis (9). For example, 
actin creates protrusions that engulf extracellular materials and assists in inward 
movement of vesicles during endocytosis (9). During muscle contraction, actin and 
myosin filaments slide past one another to generate movement (7). Neutrophils are the 
most abundant type of white blood cells in mammals and it responds to chemotactic 
stimuli by increasing actin polymerization (2). Lamellipodia are broad flat structures 
supported by orthogonal actin networks and are found at the leading edge of motile cells 
such as endothelial cells, neurons, immune cells, and epithelial cells (15). Eukaryotic 
cells depend on proper control of actin polymerization for mobility, phagocytosis, 
endocytosis, and forming contractile structures (8).  
In addition to its role in healthy cells, the actin cytoskeleton plays critical 
functions in the development and progression of diseased states in humans. For 
example, a malfunction in actin can lead to Alzheimer’s disease and metastasis of 
cancer cells (3). The microtubule associated protein tau has been known to play a role in 
the neuropathology of Alzheimer’s diseases, and recent studies suggest that tau may be 
mediating neurotoxicity by disrupting the organization and dynamics of the actin 
cytoskeleton (3). Metastasis requires extensive remodeling of the cytoskeleton, thus 
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mutations or abnormal expression of cytoskeletal and cytoskeletal-associated proteins 
cause the cancer cells to resist chemotherapy and metastasize (3). Therefore, spatial and 
temporal regulation of actin polymerization is directly related to human diseases and 
further studies on how actin cytoskeleton is regulated will improve the current 
understanding of diseased states in humans and how to treat them. 
Actin exists in two forms in the cells: monomers and filaments. Actin monomers 
assemble into filaments in a process called polymerization, which occurs over two 
phases: nucleation and elongation phase (8). During the nucleation phase, an actin 
nucleus consisting of three actin monomers is formed. While monomers can 
spontaneously collide to form dimers, these dimers are highly unstable and usually fall 
apart before colliding with a third monomer to form a nucleus (8). This large kinetic 
barrier to nucleation tightly controls the initiation of actin polymerization in cells. 
However, an actin nucleator shown in red in Figure I can stabilize the actin nucleus to 
allow the formation of actin filaments (8). In the elongation phase, monomers are 
rapidly added to the actin nucleus to form filaments, which is often facilitated by 
elongation factors such as formins (7). 
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Figure I. A cartoon showing the nucleation step of actin polymerization. This step is 
energetically unfavorable until a actin nucleator (shown in red) binds to three actin 
monomers to stabilize the actin nucleus. This energy barrier allows the cells to regulate 
actin polymerization and actin nucleators are required to nucleate new actin filaments. 
 
While capping proteins can bind at the ends of actin filaments to stop the 
polymerization, other actin-binding proteins can severe actin filaments and cause 
disassembly of actin filaments (7). Actin filaments can be either assembled in bundles 
or branched networks as shown in Figure II, and this is determined by actin-binding 
proteins that crosslink actin filaments (8). In bundles, actin filaments are crosslinked 
into closely packed parallel arrays, while in branched actin networks, actin filaments are 
loosely crosslinked orthogonal arrays that form a three-dimensional meshwork (8). The 
assembly of actin filaments is highly regulated in cells and actin-binding proteins are 
key regulators controlling where and when actin monomers will assemble into 
filaments.  
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Figure II. A cartoon showing the dynamic nature of the actin cytoskeleton. Actin-
binding proteins are responsible for promoting or inhibiting the actin polymerization. 
Capping protein (in pink), and it binds at the ends of filaments to block polymerization. 
Other actin binding proteins such as ADF/cofilin (in green) can bind to actin monomers 
and filaments and sever actin filaments to cause disassembly of actin filaments. 
Depending on which actin filament nucleator (in blue) binds to actin filaments, actin 
bundles or branches are formed. In vitro, actin filaments are constantly shrinking or 
growing in length. 
 
Actin related protein 2/3 complex (Arp2/3 complex) is one of three major 
classes of actin filament nucleator, and it is conserved in diverse species from yeast to 
human. The Arp2/3 complex is a seven-subunit protein complex capable of de novo 
formation of actin filaments, and is unique among other actin nucleators since it only 
creates branched actin filaments under most circumstances (14). The Arp2 and Arp3 
subunits are structurally homologous to actin, which allows the Arp2/3 complex to bind 
to the mother filament and initiate the growth of a new daughter filament to create 
branched actin networks (5). Branched actin networks are required for cell locomotion, 
phagocytosis, and intracellular motility of lipid vesicles (13). Previous experiments 
have shown that Arp2/3 complex is required for viability in many species including 
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yeast, flies, and worms, and Arp2/3 complex knockouts in most human cells cause cell 
death (14). Therefore, proper control of the Arp2/3 complex is required for normal 
cellular functions.  
 
Figure III. A space-filling model of bovine Arp2/3 complex from the x-ray crystal 
structure. The Arp2/3 complex consists of seven subunits, and Arp2 and Arp3 subunits 
closely resemble the structure of monomeric actin, which are thought to mimic an actin 
dimer during nucleation.  
 
The Arp2/3 complex is intrinsically inactive, and the precise mechanism for the 
activation of the Arp2/3 complex is still unknown. However, it is clear that activation of 
the Arp2/3 complex requires adenosine triphosphate (ATP), actin monomers, pre-
formed actin filaments, and nucleation promoting factors (NPFs) such as WASP (4). 
High resolution crystal structure of the inactive Arp2/3 complex shows that Arp2 and 
Arp3 subunits are touching each other in an end-to-end fashion. Upon activation, the 
Arp2/3 complex undergoes a conformational change where the Arp2 subunit moves 
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relative to the rest of the complex towards the Arp3 subunit. Previous experiments 
showed that WASP and actin monomers alone can stimulate the Arp2/3 complex to 
adopt this active conformation even in the absence of actin filaments (5). However, 
actin filaments are still required to activate the Arp2/3 complex, which led us to 
hypothesize that there may be a second set of activating conformational change in the 
Arp2/3 complex. During the actin polymerization, actin monomers become flattened 
when incorporated into the filaments, and this flattening causes all the subunits to align 
into one plane. Therefore, we hypothesize that actin filaments may cause flattening of 
Arp2 subunit and Arp3 subunit into a conformation that mimics a stable actin dimer, 
and that this conformational change is required for nucleation. No biochemical assays to 
test for the flattened conformation currently exist, so the main thrust of this work was to 
design and produce mutant Arp2/3 complexes that could be used to test our hypothesis. 
Here we describe that process, and also show our preliminary data using the mutant 
complexes. Figure IV. A cartoon model of the proposed conformational pathway to the activation of the Arp2/3 complex. In the inactive conformation, the Arp2 and Arp3 subunits are touching each other in an end-to-end fashion. Upon activation, actin monomers and WASP cause the 
Arp2 subunit to move towards the rest of the complex. The active Arp2/3 complex at the branch junction is thought to structurally mimic an actin dimer and adopt the flattened conformation to template filament formation. 
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Methods  This study seeks to develop a biochemical assay to probe the flattening of the Arp2/3 complex. We have designed a crosslinking assay with S. cerevisiae Arp2/3 complex that contains a double cysteine mutation in the same subunit located at the nucleotide binding cleft (Figure V). Based on the active structure of actin monomers, we have carefully selected and designed five cysteine pairs that are on opposite sides of the nucleotide binding cleft, which are listed in Table I. Bis-maleimidoethane (BMOE) is a short crosslinker that can crosslink two cysteine residues that are approximately 8 Angstroms apart, and it can crosslink these selected cysteine residues only when the Arp2/3 complex is in the flattened conformation. In the inactive conformation, these cysteine residues are located further than 8 Angstroms, and BMOE will not be able to crosslink them (Figure V).  
Table I. Mutations of Arp2/3 Complex 
Arp2 Arp3 
R64C/T211C V103C/N294C 
R64C/Q214C L102C/K261C 
S61C/Q214C  
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Figure V. Mutations in Arp2 subunit of the Arp2/3 Complex and the expected changes 
in the distance between these residues in the inactive conformation and the active 
conformation.   Since the Arp2 and Arp3 subunits are required for yeast viability (14), the general strategy was to introduce point mutations into the genes for Arp2 and Arp3 subunits in the context of an expression plasmid. These plasmids were then transformed into the yeast harboring a second copy of that subunit on another plasmid that could later be removed by a plasmid shuffle with 5-fluoroorotic acid (5-FOA) selection (1). After selecting for the strains that contain the mutant Arp2/3 complex, the final Arp2/3 complex protein with double cysteine mutations were harvested from the yeast. The overall strategy involves mutagenesis, transformation, plasmid shuffle, growing and harvesting, and purification of the mutant Arp2/3 complex from S. cerevisiae (Figure VI). 
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Figure VI. The overall scheme of strategies used in this project. We used site-directed 
mutagenesis to introduce point mutations into the Arp2 and Arp3 genes. We 
transformed these plasmids into the yeast strain that has a second copy of the Arp2 and 
Arp3 genes on another plasmid. Then, we used plasmid shuffle to remove the wild-type 
Arp2 and Arp3 genes. We then grew and harvested the mutant Arp2/3 complex and 
purified with gel filtration column. 
  Site-directed mutagenesis is an in-vitro method to create specific mutations using polymerase chain reaction (PCR) (13). Mutations introduced by PCR can only be incorporated into regions of sequence complementary to the primers. The primers were designed with substitutions that code for cysteine at these specific residues listed in Table I. Denaturation at 95 degrees activates the DNA polymerase and the double stranded DNA melts open to single stranded DNA. Annealing at 55-65 degrees allows the designed primers to bind to the DNA template and extension at 72 degrees allows the new DNA strand to be synthesized. These steps were repeated 28 to 30 times to make multiple copies of DNA with double cysteine mutations. Before transforming these plasmids into the yeast genome, they were sequenced to confirm that point mutations were successfully created during mutagenesis. 
Arp2 
Mutagenesi Transformati Plasmid  Grow, harvest, and purify 
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 Transformation using the Arp2 knockout strain and the Arp3 knockout strain of S. cerevisiae allows these mutant plasmids to be introduced into yeast and causes the expression of the mutant Arp2 and Arp3 subunits. These knockout strains have the URA3 marker inserted adjacent to the wild-type Arp2 or Arp3 genes that will be later used for negative selection. These mutant plasmids were first transformed into the yeast genome using lithium acetate to express the mutant Arp2 subunit and the mutant Arp3 subunit in S. cerevisiae. Then, plasmid shuffling with 5-fluoroorotic acid (5-FOA) was used to select for cells that were successfully transformed. Although 5-FOA is usually non-toxic to yeast, yeast strains expressing the functional URA3 gene converts 5-FOA to the toxic form, 5-flurouracil, and causes cell death (1). Since the wild-type Arp2/3 gene has the functional URA3 gene, only the mutant Arp2/3 genes will survive and grow on the 5-FOA plates.   After confirming the DNA sequences of the yeast cells that survived on the 5-FOA plates, these mutants were harvested with yeast extract peptone dextrose or YPD media, which is a rich medium for yeast growth. The YPD media contain all the amino acids required for yeast growth, so it is commonly used as the growth medium to grow yeast cultures (13). These mutant Arp2/3 complex were purified using a protocol developed in the Nolen lab which involves both an affinity column and a gel filtration column to separate Arp2/3 complex from other yeast proteins (13). First, yeast pellets were lysed using sonication and the proteins were separated from the mixture by high-speed centrifugation. Then, adding ammonium sulphate and overnight dialysis allowed precipitation of the proteins, and the 
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affinity column step was performed using the GST-VCA column to only elute the Arp2/3 complex protein. The SDS-page analysis was performed with coomassie staining to visualize the Arp2/3 complex. The Arp2/3 complex was further purified using SOURCE15Q ion exchange chromatography and Superdex 200 gel filtration chromatography. The SDS-page analysis was performed again as the last step to confirm the final product was the pure Arp2/3 complex, and the final concentration was measured with a spectrophotometer, UV lamp, and quartz cuvette.  To ensure these mutations did not disrupt their normal function and activity, the pyrene actin polymerization assay was performed with these Arp2/3 mutants (13). The actin polymerization assay is based on the enhanced fluorescence of pyrene-labeled actin monomers that occurs during polymerization and it monitors and records the fluorescence of pyrene-labeled actin over time. The polymerization is initiated once pyrene-labeled actin monomers are added to the mixture of Arp2/3 complex, WASP, and ATP, and the fluorescence was measured with a fluorescence spectrophotometer. The fluorescence increases as actin monomers are incorporated into the actin filament, and levels off when actin polymerization reaches the steady-state phase. The results will be analyzed by comparing the kinetics of the mutants to the kinetics of the wild-type Arp2/3 complex since our goal is to find mutants that show similar activity as the wild-type Arp2/3 complex.  One of the challenges of studying proteins and their 3-dimensional structures stems from the fact that proteins are not static and subunit interactions 
 12  
are often transient and occurs only briefly. Therefore, capturing these momentary contacts to study how they interact is one of the main goals of biochemical research, and crosslinking reagents provide the means for capturing these interactions by covalently binding them together as they interact. The crosslinking assay is a powerful tool for probing conformational changes of a protein, and involves mixing the protein of interest with a crosslinker and an activator for one minute and then stopping the crosslinking reaction with a quenching agent. Crosslinking reagents will covalently link together interacting domains by forming chemical bonds between specific amino acid functional groups that are in close proximity. For this project, the Arp2/3 complexes with double cysteine mutations were used with bis-maleimidoethane (BMOE) and WASP and the crosslinking reaction will be quenched with dithiothreitol (DTT). BMOE will crosslink these selected cysteine residues only when the Arp2 subunit and Arp3 subunit are approximately 8 Angstroms apart. Since intramolecular crosslinking increases the mobility of the subunits, it is expected the mutants that crosslink with bis-maleimidoethane (BMOE) will travel faster on the sodium dodecyl sulfate polyacrylamide gel (SDS-page gel), and a lower molecular band will be shown on the western blot. The western blot uses gel electrophoresis to separate denatured proteins by the length of the polypeptides, and the proteins are transferred to a membrane so they can be stained with antibodies specific to the target protein. For the Arp2 mutants, the antibody specific to Arp2 subunit was used while the antibody specific to Arp3 subunit was used for the Arp3 mutants.  
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Results 
The first objective of this project was to create plasmids and strains of S. 
cerevisiae that contain double cysteine mutations. The following table summarizes the 
all of the plasmids and strains that were made for this project using polymerase chain 
reaction (PCR) primers. 
 
Table II. Plasmids and Strains of S. cerevisiae 
Genotypes Plasmids Yeast Strains 
R64C/T211C pMR045 ScMR045 
R64C/Q214C pMR046 ScMR046 
S61C/Q214C pMR047 ScMR047 
V103C/N294C pMR048 ScMR048 
L102C/K261C pMR049 ScMR049 
 
 
Subsequently, these Arp2/3 complex mutants were grown and harvested in 8 L 
of YPD media and purified with gel filtration column. Figure IV shows the coomassie 
gel from the final protein purification step of R64C/Q214C mutant, and a pure Arp2/3 
complex protein was seen as indicated by seven bands each representing one subunit of 
the Arp2/3 complex. There was no evidence of degradation in these preps and they 
behaved normally on both the GST-VCA column and the SOURCE15Q column that 
were used to purify them.  
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Figure VII. The coomassie gel of R64C/Q214C mutant from the final protein 
purification step. Each band represents a subunit of the Arp2/3 complex, indicated by 
different molecular weights. Each lane represents SDS-PAGE analysis of fractions 
from the SOURCE15Q column. 
 
After all five constructs were purified, the pyrene assay was performed with 
these mutants to make sure introducing these substitution mutations did not disrupt their 
normal activity. Out of these five mutants, only R64C/Q214C mutant and 
V103C/N294C mutant showed similar activities as the wild-type Arp2/3 complex in 
pyrene assay, which are shown in Figure V. The nucleation activity of Arp2/3 complex 
is activated by members of the Wiskott-Aldrich syndrome family protein (WASP), and 
adding WASP enhanced the rate of actin polymerization when the wild-type Arp2/3 
complex, R64C/Q214C mutant, and V103C/N294C mutant were present. 
 
ARPC1 
ARP
 ARP2 
ARPC2 
ARPC4 
ARPC3 
ARPC5 
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Figure VIII. Pyrene actin polymerization assay with R64C/Q214C mutant and 
V103C/N294C mutant. The wild-type Arp2/3 complex was used as the control. These 
mutants showed similar activities as the wild-type and adding WASp enhanced the rate 
of actin polymerization. 
Figure IX. Pyrene actin polymerization assay with four flattening mutants of the Arp2/3 
complex. The wild-type Arp2/3 complex was used as the control and only 
R64C/Q214C mutant and V103C/N294C mutant showed similar activities as the wild-
type Arp2/3 complex. Other mutants showed similar baseline activity as the wild-type 
Arp2/3 complex, but adding WASp did not enhance their polymerization rate. 
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Subsequently, the R64C/Q214C mutant was used in the crosslinking reaction to 
test if BMOE can crosslink these two cysteine amino acids lining the nucleotide binding 
cleft. Since the wild-type Arp2/3 complex lacks cysteine in these residues, it was used 
as the negative control. The first lane contains the protein ladder that is used to estimate 
the size of proteins resolved by gel electrophoresis. As seen in the lanes 2-4 of the 
western blot in Figure VI, BMOE did not crosslink the wild-type Arp2/3 complex, and 
only one molecular weight band is present. However, BMOE successfully crosslinked 
the R64C/Q214C mutant regardless of the presence of absence of adenosine 
triphosphate (ATP). Although the presence of ATP was expected to increase the rate of 
crosslinking, the top band was more fainted when ATP was absent compared to the top 
band when ATP was present, indicating that the fraction of uncrosslinked Arp2/3 
complex is higher when ATP was present. 
 
 WT  R64C/Q214C 
BMOE - + +  - + + + + + + 
ATP - - +  - - + - + - + 
Figure X. The western blot showing the result of crosslinking R64C/Q214C mutant 
with BMOE. The wild-type Arp2/3 complex was used as the negative control, which 
are shown in the lanes 2-4 of this western blot. The fifth lane shows another negative 
control with the R64C/Q214C mutant and no BMOE. The sixth lane contains the 
R64C/Q214C mutant and BMOE while the seventh lane contains the R64C/Q214C 
mutant with BMOE and ATP. The reaction conditions in the lanes 6 and 7 were 
repeated in the lanes 8-11 to make sure this crosslinking was replicable.  
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To further quantify the kinetics of crosslinking and the effects of ATP on 
crosslinking reaction, the reaction was stopped at every 15 seconds until it reached one 
minute. As seen in Figure VIII, the crosslinking reaction was 50% completed 
approximately at 25 seconds when ATP was present and approximately at 10 seconds 
without ATP. At one minute, the crosslinking reaction was 84% completed when ATP 
was absent and 76% completed when ATP was present. Although the presence of ATP 
was expected to increase the crosslinking rate, the opposite was observed because the 
binding of ATP in the binding pocket of the Arp2/3 complex caused structural rigidity. 
However, when ATP is not available, ATP binding pocket is not in a locked 
conformation, which allows more flexibility in the Arp2/3 complex. Since most protein 
molecules are not static, but are in varying degrees of motion, there would be more 
chance of these two cysteine residues being closer to each other and readily available 
for crosslinking. Nonetheless, the present of ATP significantly decreased the 
crosslinking rate. 
Time (s) 0 15 15 30 30 45 45 60 60 
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ATP - - + - + - + - + 
 
Figure XI. The western blot showing the result of varying reaction time and ATP on 
crosslinking. The first lane is showing the protein ladder while the second lane is 
showing the R64C/Q214C mutant before crosslinking. The crosslinking reaction was 
stopped at every 15 seconds until it reached one minute. The lane 3 shows the result of 
crosslinking R64C/Q214C mutant with BMOE for 15 seconds when ATP was absent 
while the lane 4 shows the result of crosslinking R64C/Q214C mutant with BMOE for 
15 seconds when ATP was present. The lane 5 and 6 are showing the result of 
crosslinking the mutant with BMOE for 30 seconds without and with ATP, 
respectively. The lanes 7 and 8 are showing the result of stopping the crosslinking 
reaction after 45 seconds without and with ATP, respectively. The lanes 9 and 10 are 
showing the result of crosslinking the mutant with BMOE for one minute without and 
with ATP, respectively. 
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Figure XII. The graph showing the fraction of the R64C/Q214C mutant that are 
crosslinked as the reaction time increased. Half of the R64C/Q214C mutant were 
crosslinked approximately at 10 seconds when ATP was not present and at 25 seconds 
when ATP was present.  
 
Table III. The fraction of R64C/Q214C mutant that are crosslinked with BMOE with 
and without ATP. At one minute of crosslinking, approximately 84% of the 
R64C/Q214C mutant were crosslinked without ATP whereas 76% of the R64C/Q214C 
mutant were crosslinked with ATP.  
Time (s) Crosslinking Without ATP Crosslinking With ATP 
0 0.00 0.00 
15 0.64 0.32 
30 0.74 0.56 
45 0.80 0.66 
60 0.84 0.76 
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One of the main goals for this project was to find a set of crosslinker and double 
cysteine mutants in which crosslinking will only occur if subunit flattening occurs. This 
study confirmed that introducing R64C/Q214C mutations in the Arp2 subunit and 
V103C/N294C mutations in the Arp3 subunit did not disrupt the normal function and 
activity of the Arp2/3 complex. Also, BMOE successfully crosslinked the R64C/Q214C 
mutant. However, this study only shows the preliminary data and further studies are 
needed to determine the effects of actin filaments on the crosslinking rate, which wold 
reveal the role of actin filaments in the activation pathway of the Arp2/3 complex. 
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Future Direction 
These preliminary data suggest that there is a possibility of using the 
R64C/Q214C mutant to probe the formation of flattened conformation of the Arp2/3 
complex. Since only two out of five potential mutants were active, a second attempt to 
purify these inactive mutants should be made in case they could be useful in probing the 
flattened conformation of the Arp2/3 complex. Although only BMOE was used as the 
crosslinker in this study, Eisenberg et. al. (2013) used MTS crosslinkers with actin, and 
showed successful crosslinking. Therefore, other crosslinkers with varying distances 
could be tested to determine the most reactive crosslinker with these mutants. Also, 
different reaction conditions could be tested that would optimize the crosslinking such 
as decreasing the amount of ATP added to the crosslinking reaction. Nonetheless, we 
have made a revolutionary step in developing a biochemical assay for probing the active 
conformation of the Arp2/3 complex.  
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Glossary 
Actin: a globular multi-functional protein found in most eukaryotic cells 
Adenosine triphosphate (ATP): the energy currency of life 
Alzheimer's disease: a type of dementia that causes problem with memory, thinking, 
and behavior 
Angstrom: a unit of length equal to 0.1 nanometer 
Anneal: recombine the DNA in the double-stranded form 
Bis-maleimidoethane: a short-arm, maleimid crosslinker for covalent, irreversible 
conjugation between sulfhydryl groups  
Capping protein: a protein which binds in a calcium-independent manner to the fast-
growing ends of actin filaments 
Cell migration: a process in the development and maintenance of multicellular 
organisms which involves the translation of cells from one location to another 
Chemotactic: the movement of a microorganism or cell in response to a chemical 
stimulus 
Chemotherapy: the use of medicines or drugs to treat cancer 
Conformational change: a change in the shape of a macromolecule often induced by 
environmental factors 
Contractile apparatus: a force-generating apparatus composed of many contractile 
units called sarcomeres 
Crosslinking: the process of chemically joining two or more molecules by a covalent 
bond 
Cysteine: a sulfur-containing amino acid encoded by the codons UGU and UGC. 
Cytokinesis: the physical process of cell division, which divides the cytoplasm of a 
parental cell into two daughter cells 
Cytoskeleton: made up of microtubules, actin filaments, and intermediate filaments, 
which give the cell its shape and help organize the cells’ parts 
Denaturation: a process in which proteins or nucleic acids lose the quaternary, tertiary, 
and secondary structures, which is present in their native state 
De novo: starting from the beginning 
Dimer: a molecule or molecular complex consisting of two identical molecules linked 
together 
Endocytosis: the process of capturing a substance or particle from outside the cell by 
engulfing it with the cell membrane and bringing it into the cell 
Endothelial cells: a thin layer of simple squamous cells lining the interior surface of 
blood vessels and lymphatic vessels 
Epithelial cells: cells lining the cavities and surfaces of blood vessels and organs 
throughout the body 
Eukaryote: an organism with a nucleus and other organelles enclosed within 
membranes 
Formins: a group of proteins that are involved in the polymerization of actin 
Gel electrophoresis: a laboratory method used to separate mixtures of DNA, RNA, or 
proteins according to molecular size 
Gel filtration chromatography: separates proteins, peptides, and oligonucleotides on 
the basis of size 
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Immune cells: the cells of the immune system that are involved in protecting the body 
against infectious disease and foreign invaders 
In vitro: a process performed in a test tube, culture dish, or outside a living organism 
Lamellipodium: a cytoskeletal protein actin projection on the leading edge of the cell 
Membrane trafficking: the process by which proteins and macromolecules are 
distributed throughout the cell and released to or internalized from the extracellular 
space.  
Metastasis: the spread of a cancer cell from one part of the body to another that is not 
directly connected with it 
Microfilament: the thinnest filaments of the cytoskeleton, which is a structure found in 
the cytoplasm of eukaryotic cells 
Microtubules: filamentous intracellular structures that are responsible for movements 
in all eukaryotic cells 
Monomer: a molecule that binds to other molecules to form a polymer 
Morphogenesis: the biological process that causes an organism to develop its shape 
Mutagenesis: a process by which the genetic information of an organism is changed in 
a stable manner, resulting in a mutation 
Myosin: a large motor proteins that move along actin filaments via ATP hydrolysis 
Neuron: an electrically excitable cell that possesses and transmits information through 
electrical and chemical signals 
Neuropathology: the study of disease of nervous system tissue 
Neurotoxicity: damage to the brain or peripheral nervous system caused by exposure to 
natural or man-made toxic substances 
Neutrophil: the most abundant type of white blood cells in most mammals and form an 
essential part of the innate immune system 
Phagocytosis: the process by which a cell engulfs a solid particle to form an internal 
vesicle known as a phagosome 
Plasmid: a small, circular, double-stranded DNA molecule that is distinct from a cell’s 
chromosomal DNA 
Polymerase chain reaction (PCR): a process in molecular biology to amplify a single 
copy of  a piece of DNA across several orders of magnitude, generating thousands to 
millions of copies of a particular DNA sequence 
Polymerization: a process of reacting monomer molecules together in a chemical 
reaction to form polymer chains or three-dimensional networks 
Polypeptides: chains of amino acids. Proteins are made up of one or more polypeptide 
molecules 
Primer: a strand of short nucleic acid sequences that serves as a starting point for DNA 
synthesis 
Pyrene assay: a biochemical tool to measure the enhanced fluorescence that occurs 
during polymerization 
Quenching: a process that decreases the fluorescence intensity of a given substance 
Saccharomyces cerevisiae: a species of yeast. Also known as Brewer’s yeast 
Selective media: formulated to support the growth of group of organisms while 
inhibiting the growth of another  
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Sodium dodecyl sulfate polyacrylamide gel (SDS-page gel): a detergent that 
dissociates and unfolds oligomeric proteins into its subunits. Useful for molecular 
weight analysis of proteins 
Tau: proteins that stabilize microtubules  
Thin filament: one of the contractile elements in muscular fibers 
Vesicle: a small structure within a cell consisting of fluid enclosed by a lipid bilayer 
Western blot: analytical technique used to detect specific proteins in a sample of tissue 
homogenate or extract 
Wild-type: a strain, gene, or characteristic that prevails among individuals in natural 
conditions 
Wiskott-Aldrich syndrome protein (WASp): the founding member of a gene family 
which also includes N-WASP, and Scar. This protein is expressed in cells of the 
hematopoietic system and activates the Arp2/3 complex 
YPD media: a medium for yeast growth consisting of yeast extract peptone dextrose 
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